News

We are pleased to announce the launch of Denuding Pipettes, designed for oocyte denudation and the handling of oocytes and embryos.

A wide range of sizes is available, allowing users to select the most appropriate pipette to meet the diverse needs of assisted reproductive technology laboratories.

We remain committed to supporting the field of reproductive medicine through the continuous development of innovative products.

We are pleased to announce the launch of Zonazyme, a reagent specifically designed for the removal of the zona pellucida surrounding oocytes.

By removing the zona pellucida, this reagent may increase the likelihood that embryos which previously showed limited developmental potential can progress to the blastocyst stage, a developmental stage prepared for implantation. This approach is suitable for patients who have experienced poor embryo development in previous treatment cycles and may contribute to improved pregnancy outcomes.

We will continue to promote the development of products that contribute to enhancing reproductive medicine.

We are pleased to announce the launch of Ionomycin, an oocyte activation reagent developed for use in assisted reproductive technology.

This reagent supplies the energy required for oocyte fertilization and is indicated for patients with fertilization disorders as well as for those exhibiting age-related declines in oocyte activity. By improving fertilization rates, it contributes to enhanced pregnancy outcomes.

We will continue to promote the development of products that contribute to the advancement of reproductive medicine.

The video introduces how to freeze oligospermia with Cryotop and Oligospermia Cryo Kit.
We recommend this technique for severe male infertility treatment.